Loading component...
Loading component...
Loading component...
Respiratory clinical research services from SGS – comprehensive cross-disciplinary expertise.
Respiratory clinical research services from SGS – comprehensive cross-disciplinary expertise.
Respiratory clinical research requires a broad range of experience, multidisciplinary support and resources. As an international mid-size CRO, supporting bio/pharma clients in Europe and North America, we are recognized as the benchmark clinical research partner for quality, reliability, flexibility and customer care. Our comprehensive early and late phase expertise in pulmonary diseases, includes asthma, COPD, rhinitis, bronchiolitis and cystic fibrosis.
Benefit from our extensive experience
Our dedicated therapeutic project director provides over 30 years of experience in clinical research, and applies his expertise to your project, defining the best scientific approach for compound development, study design, execution, analysis and reporting. The project director is fully supported by a complete team of clinical and biometrics staff with therapeutic respiratory disease backgrounds.
We have conducted over 40 respiratory clinical trials in the past five years, including 17 multi-center clinical trials in respiratory and pulmonary diseases (Phase II/III) in the following Indications:
Rely on our solid respiratory clinical research expertise
With unique expertise in respiratory indications, we have specifically developed inhalation studies for asthma and COPD, including:
Enroll the right patients for your trials
With our network of clinical sites, we offer you efficient patient enrollment. Our exclusive patient center and hospital partnerships, using on-site KOLs and SGS-experienced medical staff, all work with our robust and proven quality systems.
From stand-alone support to a complete service package, our range of services include:
For expert feedback on your respiratory drug development program, contact us today.